image1

Sanofi Genzyme

Clinical Trials for CAD Sponsored by Sanofi Genzyme

image2

Apellis Pharmaceuticals Inc.

New Data from Ongoing APL-2 Phase 2 Study in Patients with Cold Agglutinin Disease and Warm Antibody Autoimmune Hemolytic Anemia at ASH

image3

BIOVERATIV

Clinical Trials Recruiting 2018

image4

Apellis Clinical Trial Recruiting

Clinical Trial Recruiting

image5

Rituximab

Rituximab was found to be effective in treating patients with Non-Hodgkins Lymphoma, its main use, however, it is now also being used in the treatment of Cold Agglutinin Disease.